Biotech

All Articles

Boehringer offers up to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and also a preclinical i...

Ventyx's last hope for inflammatory med ends in Crohn's failure

.Ventyx Biosciences' Crohn's health condition medication carried out certainly not assist clients at...

Cognition's phase 2 radiate data taint Alzheimer's possibility

.Cognition Therapeutics' phase 2 sparkle test has actually taken several of the radiance off the Alz...

BMS axes bispecific months after filing to operate stage 3 test

.Bristol Myers Squibb has actually possessed a whiplash change of mind on its BCMA bispecific T-cell...

Charles Baum takes over Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who managed Mirati Therapeutics' $ 5.8 billion purchase to Bristol Myers...

Asarina to close after initiatives to partner Tourette's medicine stop working

.After communicating to greater than 200 business to partner a Tourette syndrome therapy that presen...

Novartis markers $150M ahead of time bispecifics manage Dren Biography

.Novartis has had some rotten luck along with bispecific antibodies previously, however determining ...

AstraZeneca plants an EGFR plant along with Pinetree bargain worth $45M

.Pinetree Therapies will certainly aid AstraZeneca vegetation some plants in its pipe along with a b...

GRO gathers $60M set B to take gout arthritis treatment in to clinic

.GRO Biosciences has actually ended the full week with an added $60.3 million in the banking company...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops CEO

.Invite to recently's Chutes &amp Ladders, our roundup of notable management hirings, shootings as w...